Analyzing Generics Market in South Africa 2017

Analyzing Generics Market in South Africa 2017

  • March 2017 •
  • 80 pages •
  • Report ID: 4800434 •
  • Format: PDF
The South African generics industry has been growing at a substantial rate in recent years. It can be said that the pharmaceutical industry has become one of the fastest growing industries in the world. Amongst this, South Africa remains a clear market leader with a booming market for generics.

The South African government has been pushing for the growth of the generics market and it has led to a lot of development within this particular segment. The country is also undergoing a change in its regulatory framework to support the growth of the pharmaceutical industry as well as introducing a progressive law for intellectual property that would favor generic drugs.

Aruvian Research presents Analyzing Generics Market in South Africa 2017 – a comprehensive coverage of the South African generic drugs market. Beginning with a sectional description on the global generic industry, the report looks at an overview of the industry, an analysis of the market volume and value, industry segmentation and an industry forecast.

The Generics Industry in South Africa is analyzed through an industry overview which spans the data from 2012 till 2021. An analysis of the industry's value and volume data is included along with an industry segmentation by geography. Industry forecast of the industry is also included.

We also include a Porter’s Five Forces analysis of the South African Generics Industry.

Analysis of the major industry players in the South African generics market are analyzed through an analysis of their business segments, a financial analysis and a SWOT analysis. Players analyzed include Adcock Ingram, Cipla Limited, Aspen Pharmacare and Teva Pharmaceutical Industries. This concludes this comprehensive research report from Aruvian Research.
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.